The webinar forms part of our health professional educational program – Rheumatoid arthritis: getting the facts straight about methotrexate. Co-designed by NPS MedicineWise and the Australian Rheumatology Association, the program aims to improve the quality of life for people with rheumatoid arthritis through early investigation, diagnosis and appropriate treatment.
Webinar slide deck
The webinar presents a clinical scenario in case-study format to help facilitate the discussion and prompt participants to reflect on their individual practice and counselling of patients with rheumatoid arthritis.
Australian Prescriber: Managing the drug treatment of rheumatoid arthritis
Patients with suspected rheumatoid arthritis should be referred promptly. Disease-modifying antirheumatic drugs are often used in combination and can have serious adverse effects. Their safe use requires ongoing monitoring.
BMJ: Diagnosis and early management ofinflammatory arthritis
Early diagnosis and treatment with disease-modifying antirheumatic drugs (DMARDS) and corticosteroids improves function and symptomatic and radiographic outcomes. Prescription and monitoring of DMARDs can be shared between specialists and non-specialists if pathways and communication are clear. Specialists are best placed to guide changes in DMARDS or corticosteroid treatment.
MJA:Nocebo effects in practice – methotrexate myths and misconceptions
There are several methotrexate 'myths' that may be believed by patients and health professionals, and propagated through word of mouth, information in print or on the internet. Providing patients with accurate information will help overcome obstacles to the use of an effective treatment for rheumatoid arthritis.
Structured collaboration between patients, GPs, rheumatologists and other healthcare professionals can support an earlier start to treatment, better adherence and better outcomes. We provide an example of a shared care referral letter. Reproduced with permission.
Patientinformation on self-injecting low-dose methotrexate for the treatment ofarthritis (Australian Rheumatology Association and Arthritis Australia)
For people who have been recommended injections of methotrexate as a treatment for arthritis. Includes information about how patients and their family, friends or carers can safely inject methotrexate, the steps to follow and the equipment needed.
Keep track of your medicines and access important health info anytime and anywhere. Users of the MedicineWise app who have rheumatoid arthritis and are taking low-dose methotrexate have access to fact sheets and videos about managing their medicine(s). They will receive notifications via the app to promote the use of folic acid and the value of flu vaccinations and annual skin checks. The app allows you to set dose reminders and record tests, measurements, allergies and reactions.
A website by Arthritis Australia bringing together a range of resources for people living with arthritis, including personal stories and information from rheumatologists, general practitioners and allied health supporters.